Takeshi Kanematsu

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Five-Year Longitudinal Changes in Treatment Strategies and Clinical Outcomes in Adults With Haemophilia: The ADVANCE Japan Cohort Study.

Five-Year Longitudinal Changes in Treatment Strategies and Clinical Outcomes in Adults With Haemophilia: The ADVANCE Japan Cohort Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: April 15, 2026

Cardiovascular risk scores estimate arterial thrombotic risk in aging adults with hemophilia in the ADVANCE Japan cohort.

Cardiovascular risk scores estimate arterial thrombotic risk in aging adults with hemophilia in the ADVANCE Japan cohort.

Journal: Blood advances

Published: March 23, 2026

An exploratory plasma-based functional assay for phenotypic characterization of fibrinolysis in dysfibrinogenemia.

An exploratory plasma-based functional assay for phenotypic characterization of fibrinolysis in dysfibrinogenemia.

Journal: Research and practice in thrombosis and haemostasis

Published: January 19, 2026

Antithrombotic Therapy on Antithrombin Resistance in a Mouse Model.

Antithrombotic Therapy on Antithrombin Resistance in a Mouse Model.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: January 08, 2026

A cohort study on cardiovascular diseases in adults with hemophilia: an interim subanalysis on comorbidities and medication from ADVANCE Japan

A cohort study on cardiovascular diseases in adults with hemophilia: an interim subanalysis on comorbidities and medication from ADVANCE Japan

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

Spatiotemporal dynamics and ossification of podoplanin-positive cells in the developing femur.

Spatiotemporal dynamics and ossification of podoplanin-positive cells in the developing femur.

Journal: Scientific reports

Published: August 15, 2025

von Willebrand factor-T441N, a novel missense variant in the von Willebrand factor D2 domain, exhibits impaired multimerization and deformed Weibel-Palade bodies.

von Willebrand factor-T441N, a novel missense variant in the von Willebrand factor D2 domain, exhibits impaired multimerization and deformed Weibel-Palade bodies.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 12, 2025

Dysfibrinogenemia With the γSer358Cys Variant, Fibrinogen Milano VII, Escapes From the Clauss-CWA Classification.

Dysfibrinogenemia With the γSer358Cys Variant, Fibrinogen Milano VII, Escapes From the Clauss-CWA Classification.

Journal: International journal of laboratory hematology

Published: November 01, 2024

Prevalence Estimation of Dysfibrinogenemia Using the Clauss-CWA Approach.

Prevalence Estimation of Dysfibrinogenemia Using the Clauss-CWA Approach.

Journal: International journal of laboratory hematology

Published: July 22, 2024

Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance.

Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance.

Journal: International journal of hematology

Published: June 08, 2024

PDPN/CLEC-2 axis modulates megakaryocyte subtypes in a hematopoietic stem cell-regulating megakaryocyte-dominant manner.

PDPN/CLEC-2 axis modulates megakaryocyte subtypes in a hematopoietic stem cell-regulating megakaryocyte-dominant manner.

Journal: Thrombosis research

Published: February 01, 2024

Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance.

Newly diagnosed multiple myeloma with bleeding and coagulation abnormalities caused by a thrombin-inhibiting substance.

Journal: International journal of hematology

Published: January 31, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026